CVS Health and Adapt Pharma recently announced a partnership that will make NARCAN Nasal Spray more affordable for uninsured patients at CVS Pharmacies.
The $35 coupon reduces the cost of the life-saving medication by nearly 25 percent.
"Having a ready-to-use dose of naloxone in a nasal spray device makes administration of this life-saving medication quick and easy for friends and families of loved ones struggling with addiction in an emergency overdose situation," CVS Health VP of Pharmacy Professional Practices at CVS Health Tom Davis said. "Through this partnership with Adapt Pharma, NARCAN Nasal Spray will be more affordable for CVS Pharmacy patients who don't have insurance."
CVS Health has eliminated the need for a prescription for naloxone at CVS Pharmacies in 31 states. The NARCAN Nasal spray contains two units of naloxone hydrochloride, which are ready for use in case of an opioid overdose emergency. The easy to apply nasal spray formulation allows family, friends or caregivers to quickly apply a life-saving dose of the overdose reversal medication to the patient.
"This partnership is an important milestone in increasing access to FDA-approved naloxone formulations across U.S. communities," Adapt Pharma Chairman and CEO Seamus Mulligan said. "We are encouraged by the progress marked by CVS Pharmacy's decision to improve affordability of NARCAN Nasal Spray, especially within states with standing orders, which allow patient access to this opioid overdose treatment without physician-written naloxone prescriptions."